|
 |
FDA Approval Activities for this Drug…
Celontin (methsuximide) Capsules, Parke-Davis Limited NDA 10-596/S17 4/17/02 4/22/02 Celontin (methsuximide) Capsules, 150 mg and 300 mg Parke-Davis Pharmaceutical Research NDA 10-596/S009 & S012
For the most up-to-date approval information, please locate this API using the drug index. |
|
|